Refers to a compound of formula I, where is - n = Y1, Y1 R3 is Hydrogen or - C (H) = r3 is Fluorine or Chlorine L1 is - C (h2) - or - C (o) - CY1 is cycloalkyl optionally replaced with one or more R4 phenyl optionally substituted with one or more R5, among others R4 is Fluorine, - Oh, among others R5 IS F Luor, Chlorine, among others x1 = - n or - C (H) = r2 is Hydrogen, cycloalkyl,Lower alkyl, optionally substituted with one or more R8, among others R8 is fluoride, or lower alkoxy optionally substituted with one or more Fluorine. A Preferred Compound is: [6 - (2 - ethyl - 3 - ilamino Pyridine) - fluoro pyridine - 2 - 3 - yl] - 5 - methyl - 1H pyrrole [2,3-b] pyridine - 2 - il) methanone, among others. Also referred to a Pharmaceutical Composition and a preparation method.This Compound is a Modulator of protein kinase to be useful for the treatment of Alzheimers disease, ovarian cancer, gliomas, malignant melanomaSE REFIERE A UN COMPUESTO DE FORMULA I, DONDE: Y1 ES -N=, R3 ES HIDROGENO O Y1 ES -C(H)=, R3 ES FLUOR O CLORO L1 ES -C(H2)- O -C(O)- CY1 ES CICLOALQUILO OPCIONALMENTE SUSTITUIDO CON UNO O MAS R4, FENIL OPCIONALMENTE SUSTITUIDO CON UNO O MAS R5, ENTRE OTROS R4 ES FLUOR, -OH, ENTRE OTROS R5 ES FLUOR, CLORO, ENTRE OTROS X1 ES -N= O -C(H)=, R2 ES HIDROGENO, CICLOALQUILO, ALQUILO INFERIOR OPCIONALMENTE SUSTITUIDO CON UNO O MAS R8, ENTRE OTROS R8 ES FLUOR O ALCOXI INFERIOR OPCIONALMENTE SUSTITUIDO CON UNO O MAS FLUOR. ES UN COMPUESTO PREFERIDO: [6-(6-ETIL-PIRIDINA-3-ILAMINO)-2-FLUORO-PIRIDINA-3-IL]-(5-METIL-1H-PIRROL[2,3-b]PIRIDINA-3-IL)-METANONA, ENTRE OTROS. REFERIDO ADEMAS A UNA COMPOSICION FARMACEUTICA Y A UN METODO DE PREPARACION. DICHO COMPUESTO ES MODULADOR DE LA PROTEINA QUINASA SIENDO UTIL PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER, CANCER DE OVARIO, GLIOMAS, MELANOMA
